JPM

242.09

-0.08%↓

AXP

264.69

+0.02%↑

RY

116.82

+0.22%↑

MMC

215.29

-0.92%↓

TD

61.92

+0.15%↑

JPM

242.09

-0.08%↓

AXP

264.69

+0.02%↑

RY

116.82

+0.22%↑

MMC

215.29

-0.92%↓

TD

61.92

+0.15%↑

JPM

242.09

-0.08%↓

AXP

264.69

+0.02%↑

RY

116.82

+0.22%↑

MMC

215.29

-0.92%↓

TD

61.92

+0.15%↑

JPM

242.09

-0.08%↓

AXP

264.69

+0.02%↑

RY

116.82

+0.22%↑

MMC

215.29

-0.92%↓

TD

61.92

+0.15%↑

JPM

242.09

-0.08%↓

AXP

264.69

+0.02%↑

RY

116.82

+0.22%↑

MMC

215.29

-0.92%↓

TD

61.92

+0.15%↑

Search

KKR & Co LP

Atidarymo kaina

SektoriusFinansų sektorius

113.15 0.6

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

111.62

Max

114.01

Pagrindiniai rodikliai

By Trading Economics

Pajamos

784M

1.4B

Pardavimai

-1.5B

3.2B

P/E

Sektoriaus vid.

29.863

20.525

Pelnas, tenkantis vienai akcijai

1.32

Dividendų pajamingumas

0.71

Pelno marža

43.254

Darbuotojai

4,834

EBITDA

45M

2.5B

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+31.54% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

0.71%

4.36%

Kitas uždarbis

2025-05-01

Kita Ex Dividend data

2025-05-12

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-26B

95B

Ankstesnė atidarymo kaina

112.55

Ankstesnė uždarymo kaina

113.15

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bullish Evidence

KKR & Co LP Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-04-22 06:50; UTC

Įsigijimai, susijungimai, perėmimai

KKR Launches $1.2 Billion Takeover Bid For Swedish Life-Sciences Company Biotage

2025-04-14 11:46; UTC

Įsigijimai, susijungimai, perėmimai

CME Group, S&P Group Agree to Sell OSTTRA to KKR in $3.1 Billion Deal

2025-04-09 10:24; UTC

Įsigijimai, susijungimai, perėmimai

EQT to Sell Karo Healthcare to KKR

2025-04-09 07:09; UTC

Įsigijimai, susijungimai, perėmimai

Assura Accepts $2 Billion Takeover Offer From KKR Consortium

2025-04-09 06:02; UTC

Įsigijimai, susijungimai, perėmimai

KKR Nears $2.85 Billion Deal With EQT For E45 Maker Karo Healthcare, FT Reports, Citing Sources

2025-04-07 14:42; UTC

Įsigijimai, susijungimai, perėmimai

Assura Agrees to Primary Health Properties Bid Deadline Extension

2025-04-04 10:15; UTC

Pagrindinės rinkos jėgos
Įsigijimai, susijungimai, perėmimai

Gerresheimer Shares Fall After Report That KKR Exited Consortium Seeking Bid

2025-04-04 09:39; UTC

Įsigijimai, susijungimai, perėmimai

KKR Drops Out of Consortium Attempting Gerresheimer Takeover, Bloomberg Says, Citing Sources

2025-04-03 14:57; UTC

Įsigijimai, susijungimai, perėmimai

Primary Health Proposes $1.95 Billion Bid for Assura -- Update

2025-04-03 07:17; UTC

Įsigijimai, susijungimai, perėmimai

Primary Health Proposes $1.95 Billion Bid for Assura

2025-04-22 06:04; UTC

Įsigijimai, susijungimai, perėmimai

KKR: Offer Price Represents 60% Premium to Thursday's Closing Price

2025-04-22 06:03; UTC

Įsigijimai, susijungimai, perėmimai

KKR: Biotage Board Recommends Shareholders Accept Offer

2025-04-22 06:02; UTC

Įsigijimai, susijungimai, perėmimai

KKR: Offer Values Biotage at SEK11.61B

2025-04-22 06:02; UTC

Įsigijimai, susijungimai, perėmimai

KKR Makes SEK145 a Share Bid For Biotage

2025-04-18 00:00; UTC

Svarbiausios naujienos

Private Equity World Engulfed by Perfect Storm -- WSJ

2025-04-14 11:31; UTC

Svarbiausios naujienos
Įsigijimai, susijungimai, perėmimai

CME Group, S&P Group Agree to Sell OSTTRA to KKR in $3.1B Deal

2025-04-14 11:02; UTC

Įsigijimai, susijungimai, perėmimai

KKR: Making OSTTRA Investment Primarily Through North America Private-Equity Strategy >KKR

2025-04-14 11:01; UTC

Įsigijimai, susijungimai, perėmimai

S&P Global, CME to Divide Sale Proceeds Evenly Pursuant to 50/50 Joint Venture >SPGI CME

2025-04-14 11:00; UTC

Įsigijimai, susijungimai, perėmimai

S&P Global, CME Group to Sell OSTTRA to KKR for $3.1 Billion >SPGI CME KKR

2025-04-14 11:00; UTC

Įsigijimai, susijungimai, perėmimai

S&P Global and CME Group to Sell OSTTRA to KKR for $3.1 Billion

2025-04-11 11:56; UTC

Įsigijimai, susijungimai, perėmimai

KKR Now Owns 30% of Enilive

2025-04-11 11:55; UTC

Įsigijimai, susijungimai, perėmimai

KKR Completes Acquisition of Additional Stake in Enilive

2025-04-09 09:51; UTC

Įsigijimai, susijungimai, perėmimai

EQT to Sell Karo Healthcare to KKR for an Undisclosed Amount

2025-04-09 09:32; UTC

Įsigijimai, susijungimai, perėmimai

EQT: Transaction Expected to Close in Coming Months

2025-04-09 09:31; UTC

Įsigijimai, susijungimai, perėmimai

EQT to Sell Karo Healthcare to KKR

2025-04-03 08:17; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Primary Health Properties' Lower Bid for Assura Is a Calculated Risk -- Market Talk

2025-03-28 09:34; UTC

Įsigijimai, susijungimai, perėmimai

Topcon: Tender Offer Expected to Start Around End-July >7732.TO

2025-03-28 09:33; UTC

Įsigijimai, susijungimai, perėmimai

Topcon: CEO Takashi Eto Also Plans to Participate in Tender Offer, Make Reinvestment After Completion of Offer >7732.TO

2025-03-28 09:31; UTC

Įsigijimai, susijungimai, perėmimai

Topcon: JICC Plans to Indirectly Hold Voting Rights in Topcon >7732.TO

2025-03-28 09:31; UTC

Įsigijimai, susijungimai, perėmimai

Topcon: KKR Plans to Indirectly Hold Majority Interest in Topcon >7732.TO

Akcijų palyginimas

Kainos pokytis

KKR & Co LP Prognozė

Kainos tikslas

By TipRanks

31.54% į viršų

12 mėnesių prognozė

Vidutinis 140.5 USD  31.54%

Aukščiausias 194 USD

Žemiausias 114 USD

Remiantis 12 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines KKR & Co LP kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

12 ratings

11

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

101.87 / N/APalaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bullish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Weak Bearish Evidence

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę KKR & Co LP

KKR & Co. Inc. is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market, and middle market investments. The firm considers investments in all industries with a focus on software, security, semiconductors, consumer electronics, internet of things (iot), internet, information services, information technology infrastructure, financial technology, network and cyber security architecture, engineering and operations, content, technology and hardware, energy and infrastructure, real estate, services industry with a focus on business services, intelligence, industry-leading franchises and companies in natural resource, containers and packaging, agriculture, airports, ports, forestry, electric utilities, textiles, apparel and luxury goods, household durables, digital media, insurance, brokerage houses, non-durable goods distribution, supermarket retailing, grocery stores, food, beverage, and tobacco, hospitals, entertainment venues and production companies, publishing, printing services, capital goods, financial services, specialized finance, pipelines, and renewable energy. In energy and infrastructure, it focuses on the upstream oil and gas and equipment, minerals and royalties and services verticals. In real estate, the firm seeks to invest in private and public real estate securities including property-level equity, debt and special situations transactions and businesses with significant real estate holdings, and oil and natural gas properties. The firm also invests in asset services sector that encompasses a broad array of B2B, B2C and B2G services verticals including asset-based, transport, logistics, leisure/hospitality, resource and utility support, infra-like, mission-critical, and environmental services. Within Americas, the firm prefers to invest in consumer products; chemicals, metals and m